Based in Philippines
- Tweets 2,142
- Following 922
- Followers 2,522
- Likes 4,307
Twenty years ago tonight, Steve Gleason's blocked punt sparked a city's Rebirth. Diagnosed with ALS five years later, he founded Answer ALS. Today, his vision powers nearly 700 free global research projects.
Donate: answerals.org/donate
#Rebirth #SteveGleason #AnswerALS
2
5
377
High school students interested in STEM: join our virtual after-school program. You will work with real ALS research data, receive expert mentorship, and build valuable bioinformatics skills before you graduate. Email kelsey@onpointsci.com to learn more.
1
101
Nearly 100 peer-reviewed papers rely on Answer ALS data to uncover molecular subtypes and predict progression. Open access ensures researchers can verify findings and accelerate discovery.
Explore the research: answerals.org/research
#OpenScience #AnswerALS #ALSResearch
1
2
137
ALS and Alzheimer's share surprising molecular overlaps. For #WorldAlzheimersDay, Answer ALS datasets are accessible alongside global Alzheimer's data in the AD Workbench, empowering researchers to evaluate cross-disease mechanisms.
Explore Neuromine: dataportal.answerals.org
1
95
Batman relies on rigorous data and applied technology. Answer ALS uses the same methodology. Through Cedars-Sinai, researchers can now access nearly 1,000 participant-derived motor neuron lines connecting clinical data to Neuromine
dataportal.answerals.org #BatmanDay #ALSResearch
1
104
A researcher using Neuromine can go from a request to an analyzable ALS dataset in about two weeks. Average ALS life expectancy is two to five years. The speed of the portal is just as critical as its size. Your donations fund this rapid access
answerals.org/donate #Neuromine
1
76
Accessing an analyzable ALS dataset once required up to 18 months. Neuromine delivers data to researchers faster. Average ALS life expectancy is two to five years, making rapid access critical. Donations fund the work.
answerals.org/donate #Neuromine #AnswerALS
2
81
On Patriot Day, we honor first responders. Military veterans, athletes, and first responders develop ALS at significantly higher rates. Champion Insights is a remote study enrolling 500 participants to uncover the cause.
Enroll: ChampionInsights.org #PatriotDay #EndALS
76
90% of ALS cases are sporadic, lacking a known genetic cause. Identifying these origins requires massive datasets to reveal patterns across patient populations. Project Genesis will leverage 250 terabytes of Neuromine data to lead this search
answerals.org/research/under… #ALSResearch
1
3
238
Today is Labor Day. Nearly 35,000 Americans live with ALS. Mid-career diagnoses force tough choices about work and bring a new kind of labor: families providing continuous care. We stand with you.
answerals.org
#LaborDay #ALSCommunity #AnswerALS #EndALS #ALSAwareness
91
September 5 is International Day of Charity. Answer ALS proudly holds a Candid Platinum Seal of Transparency. Sustaining Neuromine costs $1M annually, directly equipping 700 research projects with vital data.
answerals.org/donate #InternationalDayOfCharity #AnswerALS
103
Answer ALS invested $45M in Neuromine, yielding $210M in research value across 730 projects.
Free access speeds up discovery and saves millions in resources. Annual operations cost $1M to ensure researchers pay no fees.
answerals.org/donate #Neuromine #AnswerALS
1
1
115
For decades, vital ALS data remained locked in separate labs. Neuromine harmonizes genomes, proteins, and clinical histories into one portal. Researchers can seamlessly trace 2,500 patient profiles and 1,000 stem cell lines.
dataportal.answerals.org #Neuromine #AnswerALS
83
Since 2021, Neuromine has powered 730 projects and 100 papers. Researchers in 35 countries access 250TB of ALS data and 1,000 stem cell lines for free. Over the next month, we spotlight who uses the portal and what they discover
#Neuromine #AnswerALS #EndALS
1
84
The last day of August. Where things stand: Neuromine holds 250TB of data and powers 700+ global research projects. Major new ALS initiatives are underway, and Neuromine is sharing data right now. Thank you for spending the month with us. answerals.org/donate #AnswerALS
85
As students head back to school, Answer ALS is proud to support the innovators of the future. Through Neuromine, high schoolers access the same data as scientists at Stanford, MIT, and Oxford.
Read their stories: answerals.org/news
#BackToSchool #AnswerALS
74
Today is Women’s Equality Day. We celebrate the scientists driving Answer ALS forward, from publishing foundational papers to building the Neuromine data platform. Explore the open data they help power to accelerate research: dataportal.answerals.org #WomenInSTEM #AnswerALS
1
1
71
Answer ALS is headed to Orlando for ALS Nexus 2026. Dr. Terri Thompson will present "Neuromine: A Standardized, Collaborative Data Ecosystem for ALS Discovery." Connect to discuss OMOP, interoperability and open science. answerals.org #ALSNexus2026 #AnswerALS #Neuromine
93
ALS is diagnosed in every country in the world, so research cannot stop at a border. Scientists across 35 nations now share one Neuromine dataset. Diverse patient populations and new questions combine to drive discoveries globally.
answerals.org #Neuromine #AnswerALS
100
Earlier this year, 20 international research teams each received £100,000 through the Longitude Prize on ALS, a £7.5 million global challenge using AI to find new drug targets for ALS. Nearly 100 teams entered, representing leading universities, technology companies, and AI
1
104
The Neuromine Data Portal is the largest open-access ALS research resource in the world.
It holds clinical and multi-omics data from more than 2,500 ALS patient profiles, linked to roughly 1,000 patient-derived stem cell lines and over 150 terabytes of harmonized data, including
1
1
90
The Neuromine Data Portal is used by principal investigators at leading research universities, computational biologists at major pharmaceutical companies, graduate students working on early-stage hypotheses, and biotech founders running drug discovery.
1
1
99
Answer ALS invested $45 million to build Neuromine and generate the matched stem cell lines behind it.
The average independent ALS research project costs around $200,000, so by making more than 150 terabytes of data freely available, that original investment has translated into
1
1
123
Getting from a hypothesis to an analyzable ALS dataset used to take 12 to 18 months.
With Neuromine, a researcher can go straight to data access, and to the matched biosamples that let them validate their hypothesis, in about two weeks.
1
94
Nearly 700 independent research projects have launched on the Neuromine Data Portal since 2021, with many more added in the first half of 2026 alone.
1
95
On July 4, 1939, two weeks after retiring from baseball, Lou Gehrig stood at a microphone at Yankee Stadium and told the crowd of more than 61,000 people that he considered himself the luckiest man on the face of the earth.
1
1
4
594
The last day of ALS Awareness Month. Where things stand: nearly 600 research projects launched through Neuromine. 88 peer-reviewed publications to date. Champion Insights actively enrolling toward its 500-participant target. New projects launching every week on four continents.
44
The last day of ALS Awareness Month. Where things stand: nearly 600 research projects launched through Neuromine. 88 peer-reviewed publications to date. Champion Insights actively enrolling toward its 500-participant target. New projects launching every week on four continents.
42
The last day of ALS Awareness Month. Where things stand: nearly 600 research projects launched through Neuromine. 88 peer-reviewed publications to date. Champion Insights actively enrolling toward its 500-participant target. New projects launching every week on four continents.
38
The last day of ALS Awareness Month. Where things stand: nearly 600 research projects launched through Neuromine. 88 peer-reviewed publications to date. Champion Insights actively enrolling toward its 500-participant target. New projects launching every week on four continents.
39
The last day of ALS Awareness Month. Where things stand: nearly 600 research projects launched through Neuromine. 88 peer-reviewed publications to date. Champion Insights actively enrolling toward its 500-participant target. New projects launching every week on four continents.
29
Answer ALS began with 1,100+ participants who contributed blood samples, clinical information, and long-term follow-up data. Many did not live to see what their participation would build. What their contribution built: 250 terabytes of harmonized multi-omics data. Roughly 1,000
1
49
Nearly 60 new research projects have started on Neuromine since January 2026. At this pace, Answer ALS resources will enable more than twice the research in 2026 as they did in all of 2025. The new projects include: AI-driven identification of ALS molecular subtypes, machine
1
57
Today is Memorial Day. Military veterans develop ALS at approximately twice the rate of the general population. A 2017 meta-analysis across nine studies found a 29% increased ALS risk for those who served. The reasons remain unclear. Champion Insights, our remote-participation
1
43
Our Advisory Board Chair, Ed Rapp, recently marked 10 years living with ALS. In March, Ed delivered the opening address at the Packard Center's 26th Annual ALS Research Symposium in Baltimore. He spoke about striking a balance, a theme from his final presentation at Caterpillar a
1
1
2
98
Today is a Day of Action for the ALS community. One minute: share a post about ALS with your network. Five minutes: call your representative at (202) 224-3121 and ask them to protect ALS research funding. Ten minutes: read about the early signs of ALS at
1
57
Retired Navy Lt. Commander Matt Bellina flew combat missions and led teams in the toughest environments. Now he's part of @AnswerALS's #ChampionInsights, a study investigating why military veterans face higher ALS risk. His fight continues. ChampionInsights.org
1
1
57
88 peer-reviewed scientific papers have been published using Answer ALS data and biosamples, including a foundational resource paper in Nature Neuroscience. Recent work covers ALS molecular subtypes, plasma neurofilament light chain as a prognostic biomarker, TDP-43 cryptic exon
1
1
68
Steve Gleason is Participant #1 in @AnswerALS's Champion Insights study, investigating why athletes, veterans & first responders face higher ALS risk. He gave his blood sample from home to kick it off. 500 participants. Zero barriers. ChampionInsights.org
#ChampionInsights
42
Who is actually using Neuromine? Principal investigators at Johns Hopkins, Stanford, MIT, Cedars-Sinai, Yale, Oxford, and Cambridge. Computational biologists at Bristol Myers Squibb, Merck, and Roche. Graduate students in Italy, Japan, and Australia. Biotech founders running
1
62
Champion Insights is actively recruiting.
High-performance athletes and military veterans are diagnosed with ALS at rates potentially twice that of the general population. Champion Insights is the first-of-its-kind remote study designed to find out why.
1
41
Look at who is using Neuromine for ALS research right now.\n\nBristol Myers Squibb. Eli Lilly. Novartis. GSK. Merck. AbbVie. Biogen. Regeneron. Roche. Denali. Takeda. AstraZeneca. BioMarin. And dozens of smaller biotechs building on the same foundation.
1
106
Today is GiveNOLA Day.
For 24 hours, the Greater New Orleans Foundation is running its annual community giving event.
1
31
May the 4th be with you.
Today we celebrate Steve Gleason, who founded Answer ALS in 2014 when he hosted the Team Gleason Summit and asked researchers, clinicians, and people living with ALS to build a plan to end the disease.
1
1
33
Researchers: you do not need to download terabytes of information to get started with Neuromine.
The portal's filtering tools let you query only the genes, proteins, or patient subsets relevant to your research question.
Watch a demo and get started: answerals.org/neuromine
42
